Recent evidence suggests that MITF can suppress NK‐cell‐mediated killing of melanoma cells (Sanchez‐Del‐Campo et al., 2021) and controls chemokine expression leading to reduced tumor immune infiltration in vivo (Wiedemann et al., 2019). This evidence concerns the gene MITF and melanoma.